Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Re-irradiation and Stereotactic Cetuximab in Patients With Recurrent Carcinoma of the Head and Neck

NCT00738868 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00738868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00738868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Re-irradiation and Stereotactic Cetuximab in Patients With Recurrent Carcinoma of the Head and Neck
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2007
Completion date
Not reported
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer